Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Update on the safety and immunogenicity of recombinant MVA-BN-based vaccines

May 4, 2005

Serono to develop Genmab's HuMax-TAC

May 4, 2005

GlaxoSmithKline to acquire Corixa

May 4, 2005

Isotechnika gets go-ahead for phase IIb kidney transplant study of ISA-247

May 4, 2005

ImmuFact IMP-321 enters phase I/II trials

May 3, 2005

New immunomodulatory agents disclosed by General Atomics

April 27, 2005

A new immunostimulat from intestinal Eimeria

April 25, 2005

NDA planned for orBec in iGVHD

April 22, 2005

Novel agents claimed for transplant rejection and immunological disorders

April 15, 2005

Intercell and Biological E sign Asia agreement for Japanese encephalitis vaccine

April 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...